Xylem, Inc. (NYSE: XYL) reported Q2 EPS of $0.48, $0.02 better than the analyst estimate of $0.46. Revenue for the quarter came in at $1.01 billion versus the consensus estimate of $994.85 million.

Xylem, Inc. sees FY2014 EPS of $1.90-$2.00, versus the consensus of $1.95.

For earnings history and earnings-related data on Xylem, Inc. (XYL) click here.